Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$331,010
+$331,010 QoQ
Shares Held
2,620
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,599
of 2,266 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in GILD
reported options exposure · as of Jun 30, 2026CallValue
$972,818
CallShares
7,700
PutValue
$897,014
PutShares
7,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Limestone Investment Advisors LP holds $1,815,578 across 3 Drug Manufacturers - General names. GILD ranks #2 (18.2% of the industry book) .
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $331,010 | 2,620 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $897,014 | 7,100 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $972,818 | 7,700 | Call | Sole | 2026-08-14 | |
| 2025-09-30 | $666,000 | 6,000 | Call | Sole | 2025-11-13 | |
| 2025-09-30 | $732,600 | 6,600 | Put | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||